|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.44 USD | +1.47% |
|
-6.78% | +140.56% |
| Apr. 23 | Chromadex Announces Inaugural Major Grocery Debut of Tru Niagen® At Sprouts Farmers Market | CI |
| Apr. 09 | Roth MKM Raises Price Target on ChromaDex to $6 From $4.25, Keeps Buy Rating | MT |
ChromaDex Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 83.57 million compared to USD 72.05 million a year ago. Net loss was USD 4.94 million compared to USD 16.54 million a year ago.
Basic loss per share from continuing operations was USD 0.07 compared to USD 0.24 a year ago. Diluted loss per share from continuing operations was USD 0.07 compared to USD 0.24 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +140.56% | 260M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
CHROMADEX CORPORATION 
